Trials / Completed
CompletedNCT01385696
Study Evaluating Preference, Satisfaction and Ease of Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD) Diagnosed Patients
Study Evaluating Preference, Satisfaction and Ease of Use of Inhalers in COPD Diagnosed Patients
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 130 (actual)
- Sponsor
- Almirall, S.A. · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
Preference study: Genuair vs HandiHaler inhalers in COPD patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Genuair® (Almirall S.A.) | Inhaler with only placebo, once daily, 14 days |
| DEVICE | HandiHaler® (Boehringer Ingelheim's) | Inhaler with only placebo, once daily, 14 days |
Timeline
- Start date
- 2011-06-01
- Primary completion
- 2012-01-01
- Completion
- 2012-01-01
- First posted
- 2011-06-30
- Last updated
- 2015-06-24
- Results posted
- 2013-04-22
Locations
4 sites across 2 countries: Germany, Netherlands
Source: ClinicalTrials.gov record NCT01385696. Inclusion in this directory is not an endorsement.